Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Immunic, Inc. (IMUX) had Return on Tangible Equity of -79.09% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-26.82M |
|
-- |
|
-- |
|
$27.08M |
|
$-27.08M |
|
$0.26M |
|
$-26.82M |
|
$-26.82M |
|
$-26.82M |
|
$-26.82M |
|
$-26.82M |
|
$-26.82M |
|
$-27.08M |
|
$-27.04M |
|
132.18M |
|
132.18M |
|
$-0.20 |
|
$-0.20 |
|
| Balance Sheet Financials | |
$59.84M |
|
$0.61M |
|
$1.59M |
|
$61.43M |
|
$27.31M |
|
-- |
|
$0.20M |
|
$27.52M |
|
$33.91M |
|
$33.91M |
|
$33.91M |
|
98.65M |
|
| Cash Flow Statement Financials | |
$-46.38M |
|
$-0.08M |
|
$65.52M |
|
$35.67M |
|
$55.31M |
|
$19.64M |
|
$3.94M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.19 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-46.47M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-79.09% |
|
|
Return on Tangible Equity |
-79.09% |
-43.66% |
|
-79.09% |
|
$0.34 |
|
$-0.35 |
|
$-0.35 |
|